Indication

Autoimmune Liver Disease

1 clinical trial

1 product

Clinical trial

A 12-Month, Open-Label Study Evaluating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Siplizumab as Induction Therapy in Patients With Autoimmune Liver Diseases Undergoing Liver Transplantation (SET-SAIL)

Status: Not yet recruiting, Estimated PCD: 2025-12-31

Product